NASDAQ : AMRN
Amarin Corporation plc — Key statistics
Healthcare · Drug Manufacturers - General · Ireland
Last price 12.11 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 255.20M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 255.62M |
| Enterprise Value | -60.15M |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | n/a |
| Shares Outstanding | 21.07M |
| Shares Change (YoY) | +1.30% |
| Shares Change (QoQ) | +2.74% |
| Owned by Insiders (%) | 1.94% |
| Owned by Institutions (%) | 14.81% |
| Float | 19.36M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.45 |
| Forward PS | 1.48 |
| PB Ratio | 0.58 |
| P/TBV Ratio | 0.59 |
| P/FCF Ratio | 6.82 |
| P/OCF Ratio | 6.82 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.50 |
| Quick Ratio | 2.49 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.20 |
| Interest Coverage | -3,514.57 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -4.24% |
| Return on Assets (ROA) | -2.38% |
| Return on Invested Capital (ROIC) | -18.58% |
| Return on Capital Employed (ROCE) | -5.36% |
| Weighted Average Cost of Capital (WACC) | 8.23% |
| Revenue Per Employee | $2.20M |
| Profits Per Employee | -$239,263 |
| Employee Count | 80 |
| Asset Turnover | 0.27 |
| Inventory Turnover | 0.61 |
Taxes
| Measure | Value |
|---|
| Income Tax | 2.01M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.77 |
| 52-Week Price Change | -25.54% |
| 50-Day Moving Average | 12.93 |
| 200-Day Moving Average | 14.30 |
| Relative Strength Index (RSI) | 47.02 |
| Average Volume (20 Days) | 72,397 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 532,662 |
| Short Previous Month | 528,373 |
| Short % of Shares Out | 1.28% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 8.68 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 176.11M |
| Gross Profit | 72.11M |
| Operating Income | -24.60M |
| Pretax Income | -17.13M |
| Net Income | -19.14M |
| EBITDA | -21.99M |
| EBIT | -24.60M |
| Loss Per Share | -$0.91 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 323.38M |
| Total Debt | 7.61M |
| Net Cash | 315.77M |
| Net Cash Per Share | $14.98 |
| Equity (Book Value) | 444.41M |
| Book Value Per Share | 21.08 |
| Working Capital | 437.74M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 37.49M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 2.62M |
| Net Borrowing | n/a |
| Free Cash Flow | 37.49M |
| FCF Per Share | $1.78 |
Margins
| Measure | Value |
|---|
| Gross Margin | 40.94% |
| Operating Margin | -13.97% |
| Pretax Margin | -9.73% |
| Profit Margin | -10.87% |
| EBITDA Margin | -12.48% |
| EBIT Margin | -13.97% |
| FCF Margin | 21.29% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.30% |
| Shareholder Yield | -1.30% |
| Earnings Yield | -7.53% |
| FCF Yield | 14.67% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $12.50 |
| Price Target Difference | 3.05% |
| Analyst Consensus | Strong Sell |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | -4.67% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Apr 11, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -1.83 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |